Novartis AG - Depositary Receipt (Common Stock)
DE ˙ DB ˙ US66987V1098
121,00 € 0,00 (0,00%)
2026-06-04
DEL PRIS
SecurityDE:NOTA / Novartis AG - Depositary Receipt (Common Stock)
InstitutionDavidson Trust Co
Latest Disclosed Ownership3,685 shares
Latest Disclosed Value $ 562,884
Davidson Trust Co reports 1.39% decrease in ownership of NOTA / Novartis AG - Depositary Receipt (Common Stock)

On April 20, 2026 - Davidson Trust Co filed a 13F-HR form disclosing ownership of 3,685 shares of Novartis AG - Depositary Receipt (Common Stock) (DE:NOTA) valued at $473,522 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 3,737 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -1.39% during the quarter. The current value of the position is $445,885 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-20 2026-03-31 13F NOVARTIS AG ADR Equities 66987V109 3,685 -52 -1.39 563 9.13 0.2303
2026-01-27 2025-12-31 13F NOVARTIS AG ADR Equities 66987V109 3,737 -673 -15.26 515 -8.85 0.2027
2025-10-20 2025-09-30 13F NOVARTIS AG ADR Equities 66987V109 4,410 -122 -2.69 566 3.10 0.2335
2025-07-28 2025-06-30 13F NOVARTIS AG ADR Equities 66987V109 4,532 -605 -11.78 548 -4.20 0.2531
2025-04-29 2025-03-31 13F NOVARTIS AG ADR Equities 66987V109 5,137 -5,771 -52.91 573 -46.09 0.2731
2025-01-31 2024-12-31 13F NOVARTIS AG ADR Equities 66987V109 10,908 707 6.93 1,061 -9.55 0.5463
2024-11-13 2024-09-30 13F NOVARTIS AG ADR Equities 66987V109 10,201 1,770 20.99 1,173 30.77 0.6028
2024-07-31 2024-06-30 13F NOVARTIS AG ADR Equities 66987V109 8,431 -73 -0.86 898 9.12 0.6185
2024-05-13 2024-03-31 13F NOVARTIS AG ADR Equities 66987V109 8,504 640 8.14 823 3.53 0.4793
2024-01-31 2023-12-31 13F NOVARTIS AG ADR Equities 66987V109 7,864 112 1.44 794 0.63 0.5121
2023-11-09 2023-09-30 13F NOVARTIS AG ADR Equities 66987V109 7,752 -36 -0.46 790 0.51 0.5857
2023-08-10 2023-06-30 13F NOVARTIS AG ADR Equities 66987V109 7,788 1,735 28.66 786 41.19 0.5684
2023-04-24 2023-03-31 13F NOVARTIS AG ADR Equities 66987V109 6,053 736 13.84 557 15.35 0.4287
2023-02-15 2022-12-31 13F NOVARTIS AG ADR Equities 66987V109 5,317 81 1.55 482 21.11 0.4263
2022-11-07 2022-09-30 13F NOVARTIS AG ADR Equities 66987V109 5,236 -384 -6.83 398 -16.21 0.3824
2022-07-27 2022-06-30 13F NOVARTIS AG ADR Equities 66987V109 5,620 -142 -2.46 475 -6.13 0.4234
2022-05-12 2022-03-31 13F NOVARTIS AG ADR Equities 66987V109 5,762 -307 -5.06 506 -4.53 0.3762
2022-01-28 2021-12-31 13F NOVARTIS AG ADR Equities 66987V109 6,069 -284 -4.47 530 1.92 0.3640
2021-11-03 2021-09-30 13F NOVARTIS AG ADR Equities 66987V109 6,353 712 12.62 520 0.97 0.3969
2021-08-10 2021-06-30 13F NOVARTIS AG ADR Equities 66987V109 5,641 -312 -5.24 515 1.58 0.4013
2021-05-07 2021-03-31 13F NOVARTIS AG ADR Equities 66987V109 5,953 -259 -4.17 507 -13.33 0.4258
2021-02-10 2020-12-31 13F NOVARTIS AG ADR Equities 66987V109 6,212 -202 -3.15 585 5.22 0.5025
2020-11-02 2020-09-30 13F NOVARTIS AG ADR Equities 66987V109 6,414 108 1.71 556 1.09 0.5052
2020-08-11 2020-06-30 13F NOVARTIS AG ADR Equities 66987V109 6,306 502 8.65 550 15.30 0.5343
2020-05-06 2020-03-31 13F NOVARTIS AG ADR Equities 66987V109 5,804 -80 -1.36 477 -14.21 0.5883
2020-02-14 2019-12-31 13F NOVARTIS AG ADR Equities 66987V109 5,884 5,884 556 0.5606
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.